Annis Gardner Whiting Capital Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,135
Closed -$118K – 1076
2026
Q1
$118K Hold
6,135
– – 0.02% 410
2025
Q4
$116K Sell
6,135
-925
-13% -$17.1K 0.02% 375
2025
Q3
$132K Hold
7,060
– – 0.03% 338
2025
Q2
$130K Hold
7,060
– – 0.05% 270
2025
Q1
$123K Hold
7,060
– – 0.05% 242
2024
Q4
$122K Hold
7,060
– – 0.03% 253
2024
Q3
$131K Hold
7,060
– – 0.04% 251
2024
Q2
$109K Hold
7,060
– – 0.03% 291
2024
Q1
$104K Hold
7,060
– – 0.04% 273
2023
Q4
$101K Hold
7,060
– – 0.04% 220
2023
Q3
$98.4K Buy
+7,060
New +$90.3K 0.05% 210

Other funds holding SBRA

Annis Gardner Whiting Capital Advisors's SBRA Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 6,135 shares — an estimated $118K sold.

Annis Gardner Whiting Capital Advisors first reported a position in SBRA in Q3 2023 and held it in 11 quarters. The position peaked at $132K in Q3 2025. 466 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 6,135 Sabra Healthcare REIT shares in Q2 2026, an estimated $118K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Sabra Healthcare REIT in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's Sabra Healthcare REIT position peaked at $132K in Q3 2025.
  • 466 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.